• Harvard College A.B. magna cum laude 1980
  Major: Biochemical Sciences
• Cornell University Medical College M.D. 1985

• New York Hospital-Cornell Medical Center 1985 - 1986
• UCLA Neuropsychiatric Institute 1986 - 1989
• Chief Resident, UCLA Neuropsychiatric Institute Adult Inpatient Service 1988 - 1989

• Division of Neurobehavior, Department of Neurology
  UCLA School of Medicine 1989 - 1991

• California 1986

• American Board of Psychiatry & Neurology:
  • Psychiatry 1991
  • Addiction Psychiatry 1994
  • Geriatric Psychiatry 1994
  • Forensic Psychiatry 1998
• American Society of Addiction Medicine:
  • Addiction Medicine 1994
  • Medical Review Officer 1995

• Associate Clinical Professor of Psychiatry (Compensated Series)
  UCLA School of Medicine 2000-present

• Medical Director, Psychiatric Intensive Care Unit
  VA Greater Los Angeles Healthcare System 1998 - present
• Private practice of clinical & forensic psychiatry 1997 - present

• Chief, Intensive Outpatient Treatment of Addictions Day Hospital
  VA Medical Center West Los Angeles 1995 - 1997
• Chief, Substance Abuse Consultation Team
  VA Medical Center West Los Angeles 1995
• Program Director, Alcohol & Drug Treatment Program
  VA Medical Center West Los Angeles 1992 - 1995
• Volunteer Psychiatrist, UCLA Student Psychological Services 1989-91

• UCLA Forensic Psychiatry Fellowship 1992 - present
• Director of Psychiatric Intensive Care Unit Residency Training
  VA Medical Center West Los Angeles 1998 - present
• Director of Substance Abuse Residency Training
  VA Medical Center West Los Angeles 1991 - 1997
• Lecturer, PG-3 Psychopharmacology Course
  UCLA Neuropsychiatric Institute 1993 - present
• Supervision of Psychiatry Residents
  UCLA Neuropsychiatric Institute
  Harbor - UCLA Medical Center
  UCLA - San Fernando Valley psychiatry training programs 1988 - present
• Supervision of Addiction Therapists
  VA Medical Center West Los Angeles 1991 - 1997

• Distinguished Fellow, American Psychiatric Association, 2003
• Fellow, American Psychiatric Association, 2001
• VA Innovations of Care, Department of Veterans Affairs
  Recognition of the Intensive Outpatient Treatment of Addictions Program, 1997
• Oskar Diethelm Prize for Excellence in Psychiatry Cornell University Medical College, 1985

• Sexual Offender Committee 2003 - present
  American Academy of Psychiatry & the Law
• Addition Psychiatry Committee, 1998 - present
  American Academy of Psychiatry & the Law
• Co-Chair, Patient Rights Committee, 1998 - present
  VA Greater Los Angeles Healthcare System
• Research & Development Committee 1993 - 1996
  VA Medical Center West Los Angeles

• Expert Reviewer, California Medical Board 2000 - present
• Sexual Recovery Institute 1998 - 2003
• AIM Heathcare Foundation 1998 - 2001
• Ventura County Sheriff's Department 1998 - 1999
• Didi Hirsh Community Mental Health Center 1988 - 1998

• American Society for Adolescent Psychiatry
• Association for the Treatment of Sexual Abusers
• American Academy of Addiction Psychiatrists
• Association of Threat Assessment Professionals
• National Council on Sexual Addiction & Compulsivity
• American Academy of Psychiatry & the Law
• American Academy of Forensic Sciences
• American Society of Addiction Medicine
• American Psychiatric Association

• Research Psychiatrist
  National Institute on Drug Abuse-Medication Development Unit (NIDA-MDU)
  VA Medical Center West Los Angeles 1991 - 1997
• (Director of Clinical Trials, NIDA-MDU 1995 - 1996)
• (Co-Director of Neuroimaging, NIDA-MDU 1994 - 1996)

• Clinical trial of LAAM in opiate dependence
• Clinical trial of bupropion in crack cocaine dependence
• Clinical trial of selegiline in crack cocaine dependence
• Brain MRI evaluation of crack cocaine dependence
• PET/MRI evaluation of cocaine infusion
• Human infusion study of cocaine

• "Behavioral Addictions & Forensic Issues: Sexual Addiction." American Academy of Psychiatry & the Law, Boston, Massachusetts, October 25, 2001
  
  
• "Boundary Issues in Addiction Treatment." American Academy of Psychiatry & the Law, Baltimore, Maryland, October 15, 1999
  
  
• "Sexual Addiction." Century City Bar Association, Los Angeles, California, May 5, 1999
  
  
• "Forensic Aspects of Psychopharmacology." Los Angeles County Department of Mental Health, Los Angeles, California, February 4, 1999
  
  
• "Sex, Drugs, & Compulsivity: HIV Risk & Clinical Medication Trials." College on Problems of Drug Dependence, Scottsdale, Arizona, June 1995

• Beckson M, Bartzokis G., Weinstock R. Substance abuse & addiction in forensic psychiatry. In: Rosner R, Ed. Principles & Practice of Forensic Psychiatry, 2nd Edition. London: Arnold, 2003.
  
  
• Beckson M, Bartzokis G. Brain disease: Forensic neuropsychiatric issues. In: Rosner R, Ed. Principles & Practice of Forensic Psychiatry, 2nd Edition. London: Arnold, 2003.
  
  
• Bartzokis G, Beckson M, Lu PH, Edwards N, Bridge P, Mintz J. Brain maturation may be arrested in chronic cocaine addicts. Biological Psychiatry 51:605-612, 2002.
  
  
• Beckson M. Smack is back: Heroin in the 21st century. Century City Lawyer, 11(8) 19-22, 2002.
  
  
• Bartzokis G, Beckson M, Lu PH, Neuchterlein K, Edwards N, Mintz J. Age-related changes in frontal & temporal lobe volumes in men: A magnetic resonance imaging study. Arch Gen Psychiatry 58(5): 461-465, 2001.
  
  
• Bartzokis G, Beckson M, Po H, Edwards N, Rappaport R, Wiseman E, Bridge P. Increased CSF volumes are associated with diminished subjective response to cocaine infusion. Neuropsychopharmacology 23(4): 468-473, 2000.
  
  
• Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P. Age-related brain volume changes in amphetamine & cocaine addicts & normal controls: implications for addiction risk? Psychiatric Research (Neuroimaging Section)98(2): 93-102, 2000.
  
  
• Ettlin TM, Kischka U, Beckson M, Gaggiotti M, Rauchfleisch U, Benson DF. The Frontal Lobe Score: part I: construction of a mental status of frontal systems. Clinical Rehabilitation 14: 260-271, 2000.
  
  
• Bartzokis G, Lu PH, Beckson M, Rapoport R, Grant S, Wiseman E, London ED. Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology 22(1): 102-3, 2000.
  
  
• Bartzokis G, Goldstein IB, Hance DB, Beckson M, Shapiro D, Lu P, Edwards N, MIntz J, Bridge P. Risk of cerebrovascular toxicity in cocaine dependence is age-related & region-specific. American Journal of Neuroradiology 20(9): 1628-1635, 1999.
  
  
• Newton TF, Kalechstein A, Beckson M, Bartzokis G, Bridge TP, Ling W. Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatric Res 87(2-3): 101-6, 1999.
  
  
• Bartzokis G, Goldstein IB, Hance DB, Beckson M, Shapiro D, Lu PH, Edwards N, Mintz J, Bridge P. The incidence of T2-weighted MR imaging signal abnormalities in the brain of cocaine-dependent patients is age-related & region-specific. Am J Neuroradiol 20(9): 1628-35, 1999.
  
  
• Bartzokis G, Beckson M, Newton T, Mandelkern M, Foster JA, Ling W, Bridge P. Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism & subjective ratings of euphoria. Neuropsychopharmacology 20: 582-90, 1999.
  
  
• Bartzokis G, Beckson M, Wirshing DA, Lu P, Foster JA, Mintz J. Choreoathetoid movements in cocaine dependence. Biological Psychiatry 45: 1630-5, 1999.
  
  
• Barzokis G, Beckson M, Hance DB, Lu P, Foster JA, Mintz J, Ling W, Bridge P. MRI evidence of "silent" neurovascular toxicity in cocaine dependence. Biological Psychiatry 45: 1203-11, 1999.
  
  
• Beckson M. Sexual addiction. Century City Lawyer 9(6): 8-10, 1999.
  
  
• Beckson M. Marijuana: Mental & behavioral aspects. Century City Lawyer 8(1):12-3, 1999.
  
  
• Bartzokis G, Beckson M. MRI evaluation of neurotoxicity in cocaine users. In Drugs of Abuse in the Decade of the Brain, Gariel G. Nahas, ed. Cambridge, Massachusetts: I.O.S. Press, pp. 249-57, 1997.
  
  
• Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR. MR evaluation of age-related increase of brain iron in young adult & older normal males. Magn Reson Imaging 15(1): 29-35, 1997.
  
  
• Bartzokis G, Beckson M. Clinical & MRI evaluation of psychostimulant neurotoxicity. In Neurotoxicity & Neuropathology Associated with Cocaine Abuse, MD Mjewska, ed. (NIDA Research Monograph Series 163:300-17). U.S. Department of Health & Human Services, 1996.
  
  
• Beckson M, Schaefer M. Sex, drugs, & compulsivity: HIV risk & clinical medication trials. In Problems of Drug Dependence 1995: Proceedings of the Fifty-Seventh Annual Scientific Meeting, College on Problems of Drug Dependence, Inc. (NIDA Research Monograph Series 162:46-8). U.S. Department of Health & Human Services, 1996.
  
  
• Beckson M, Benson DF. Brain disease & abnormal behavior. In: Richard Rosner, ed. Principles & Practice of Forensic Psychiatry. New York: Chapman & Hall, 1994.
  
  
• Beckson, Ling W. Pharmacologic interventions in cocaine dependence. Southern California Psychiatrist 41(10):10-1, 1993.
  
  
• Beckson M, Cummings JL. Psychosis in basal ganglia disorders. Neuropsychiatry, Neuropsychology, & Behavioral Neurology 5:126-31, 1992.
  
  
• Beckson M, Cummings JL. Neuropsychiatric aspects of stroke. International Journal of Psychiatry in Medicine 21(1):1-15, 1991.

Please let the Experts know you found them @ Ca-Experts.Com